Get started
Author

Eloise Chapman‐Davis

Observed names: Chapman-Davis, Eloise, E Chapman-Davis, E. Chapman-Davis, Eloise Chapman-Davis
Observed institutions: Northwestern University, Tufts University, MedStar Washington Hospital Center, Tufts Medical Center, Memorial Sloan Kettering Cancer Center, NewYork–Presbyterian Hospital, Georgetown University, Virginia Commonwealth University, Washington University in St. Louis, Cornell University, Cancer Genetics (United States), Advocate Christ Medical Center, Weill Cornell Medicine, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Weill Cornell Medical Center, Stony Brook University
ORCID: 0000-0002-1349-8579
Observed ORCID: 0000-0002-1349-8579
OpenAlex ID: A5086089361
Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma
2019 · Panagiotis A. Konstantinopoulos, Steven Waggoner, et al. · JAMA Oncology · 565
PDF
Gynecologic cancer disparities: A report from the Health Disparities Taskforce of the Society of Gynecologic Oncology
2014 · Yvonne Collins, Kevin Holcomb, et al. · Gynecologic Oncology · 250
Role of Progesterone in Endometrial Cancer
2010 · J. Kim, Eloise Chapman-Davis · Seminars in Reproductive Medicine · 213
Racial and Ethnic Disparities in Genetic Testing at a Hereditary Breast and Ovarian Cancer Center
2020 · Eloise Chapman-Davis, Zhen Ni Zhou, et al. · Journal of General Internal Medicine · 163
PDF
Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis
2022 · Melissa K. Frey, Muhammad Danyal Ahsan, et al. · Journal of Clinical Oncology · 145
TOPACIO/Keynote-162 (NCT02657889): A phase 1/2 study of niraparib + pembrolizumab in patients (pts) with advanced triple-negative breast cancer or recurrent ovarian cancer (ROC)—Results from ROC cohort.
2018 · Panagiotis A. Konstantinopoulos, Steven E. Waggoner, et al. · Journal of Clinical Oncology · 143
Impact of the coronavirus disease 2019 pandemic on the quality of life for women with ovarian cancer
2020 · Melissa K. Frey, Annie E. Ellis, et al. · American Journal of Obstetrics and Gynecology · 119
PDF
Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: Factors associated with resistance to single-agent methotrexate chemotherapy
2012 · Eloise Chapman-Davis, Anna V. Hoekstra, et al. · Gynecologic Oncology · 100
Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysis
2021 · Jenny Lin, Ravi N. Sharaf, et al. · Gynecologic Oncology · 92
Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population?
2019 · Ryan M. Kahn, Sushmita Gordhandas, et al. · Cancer · 89
PDF
Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling
2020 · Melissa K. Frey, Ryan M. Kahn, et al. · Journal of Clinical Oncology · 86
Transgelin 2 guards T cell lipid metabolism and antitumour function
2024 · Sung-Min Hwang, Deepika Awasthi, et al. · Nature · 78
PDF
Rhabdomyosarcoma of the lower female genital tract: an analysis of 144 cases
2017 · Dimitrios Nasioudis, Michail Alevizakos, et al. · Archives of Gynecology and Obstetrics · 72
Gynecologic oncology care during the COVID-19 pandemic at three affiliated New York City hospitals
2020 · Melissa K. Frey, Rana K. Fowlkes, et al. · Gynecologic Oncology · 51
PDF
Management and prognosis of ovarian yolk sac tumors; an analysis of the National Cancer Data Base
2017 · Dimitrios Nasioudis, Eloise Chapman-Davis, et al. · Gynecologic Oncology · 49
Safety of ovarian preservation in premenopausal women with stage I uterine sarcoma
2017 · Dimitrios Nasioudis, Eloise Chapman-Davis, et al. · Journal of Gynecologic Oncology · 49
PDF
Prognostic significance of lymphadenectomy and prevalence of lymph node metastasis in clinically-apparent stage I endometrioid and mucinous ovarian carcinoma
2016 · Dimitrios Nasioudis, Eloise Chapman-Davis, et al. · Gynecologic Oncology · 49
Financial toxicity, mental health, and gynecologic cancer treatment: The effect of the COVID‐19 pandemic among low‐income women in New York City
2021 · Yiting Stefanie Chen, Zhen Ni Zhou, et al. · Cancer · 43
PDF
Chatbot Artificial Intelligence for Genetic Cancer Risk Assessment and Counseling: A Systematic Review and Meta-Analysis
2023 · Emily M. Webster, Muhammad Danyal Ahsan, et al. · JCO Clinical Cancer Informatics · 40
PDF
Feasibility and Learning Curve of Robotic Laparoendoscopic Single-Site Surgery in Gynecology
2016 · Alexandre Buckley de Meritens, Julia Kim, et al. · Journal of Minimally Invasive Gynecology · 39
Adapting and avoiding coping strategies for women with ovarian cancer during the COVID-19 pandemic
2020 · Melissa K. Frey, Eloise Chapman-Davis, et al. · Gynecologic Oncology · 38
PDF
Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma?
2017 · Dimitrios Nasioudis, Eloise Chapman-Davis, et al. · Journal of Gynecologic Oncology · 38
PDF
Do people with hereditary cancer syndromes inform their at-risk relatives? A systematic review and meta-analysis
2023 · Muhammad Danyal Ahsan, Sarah R. Levi, et al. · PEC Innovation · 37
Fertility-preserving surgery for advanced stage ovarian germ cell tumors
2017 · Dimitrios Nasioudis, Melissa K. Frey, et al. · Gynecologic Oncology · 37
Fertility sparing surgery for patients with FIGO stage I clear cell ovarian carcinoma: a database analysis and systematic review of the literature
2020 · Dimitrios Nasioudis, Lakeisha Mulugeta-Gordon, et al. · International Journal of Gynecological Cancer · 35
Works count: 244
Citation count: 3,373
H-index: 30
I10-index: 54
Year
Topic
Type